Cboe Global Markets, Inc.

  • Market Cap: Mid Cap
  • Industry: Capital Markets
  • ISIN: US12503M1080
USD
291.78
1.88 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cboe Global Markets, Inc. stock-summary
stock-summary
Cboe Global Markets, Inc.
Capital Markets
Cboe Global Markets, Inc. is a holding company that provides trading and investment solutions to investors around the world. The Company offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, United States and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and multi-asset volatility products based on the Cboe Volatility Index (VIX Index). The Company’s trading venues include the options exchange in the United States and the stock exchange in Europe. Its products include VIX Index & Volatility, stock exchange options, options on single stocks and exchange traded products, Mini Options, Weeklys Options, Strategy Benchmark Indexes, Social Media Indexes, Contract Specs and Trading Hours and Trader Incentive Programs. Through its subsidiary, Hanweck Associates, LLC, it delivers real-time risk and margin analytics on global derivatives markets.
Company Coordinates stock-summary
Company Details
400 S La Salle St , CHICAGO IL : 60605-1023
stock-summary
Tel: 1 312 78672001 312 7867136
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 139 Schemes (38.13%)

Foreign Institutions

Held by 369 Foreign Institutions (23.96%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Edward Tilly
Chairman of the Board, President, Chief Executive Officer
Mr. Eugene Sunshine
Lead Independent Director
Mr. Ivan Fong
Director
Mr. Alexander Matturri
Director
Ms. Jennifer McPeek
Director
Mr. William Farrow
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,204 Million
(Quarterly Results - Dec 2025)
Net Profit:
312 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 36,254 Million (Mid Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.81%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

21.94%

stock-summary
Price to Book

7.06